These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3343515)

  • 41. Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas.
    Bhattacharya M; Chatterjee SK; Barlow JJ; Fuji H
    Cancer Res; 1982 May; 42(5):1650-4. PubMed ID: 6175395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Preparation and properties of monoclonal antibodies to influenza virus A/Krasnodar/101/59 (H2N2)].
    Nagieva FG; Nikulina VG; Kuznetsova EI; Koptiaeva IB; Krasnova NI; Ageeva ON; Andzhaparidze OG
    Vopr Virusol; 1989; 34(5):543-7. PubMed ID: 2609638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single-step cloning of a hybridoma producing a monoclonal antibody against a target protein.
    Orii H; Yamaguchi T; Watanabe K
    Anal Biochem; 2013 Mar; 434(1):52-3. PubMed ID: 23146588
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hybridomas producing hemolytic plaques used to study the relationship between monoclonal antibody affinity and the efficiency of plaque inhibition with increasing concentrations of antigen.
    Bankert RB; Mazzaferro D; Mayers GL
    Hybridoma; 1981; 1(1):47-58. PubMed ID: 6765319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of postfusion cell density on establishment of hybridomas.
    Kontseková E; Novák M; Kontsek P; Borecký L; Lesso J
    Folia Biol (Praha); 1988; 34(1):18-22. PubMed ID: 3391325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Age-related natural antibody specificities among hybridoma clones originating from NZB spleen.
    Dighiero G; Lim A; Poncet P; Kaushik A; Ge XR; Mazié JC
    Immunology; 1987 Nov; 62(3):341-7. PubMed ID: 3666786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Preparation and characterization of monoclonal antibodies against M2 protein of avian influenza virus].
    Li YQ; Yang J; Zhang L; Wei L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 May; 24(5):475-8. PubMed ID: 18466706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimation of the number of monoclonal hybridomas in a cell fusion experiment. Effect of post-fusion cell dilution on hybridoma survival.
    De Blas AL; Ratnaparkhi MV; Mosimann JE
    J Immunol Methods; 1981; 45(2):109-15. PubMed ID: 7288193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Production of T-T hybrids from T cell clones. Direct comparison between cloned T cells and T hybridoma cells derived from them.
    Ozaki S; Durum SK; Muegge K; York-Jolley J; Berzofsky JA
    J Immunol; 1988 Jul; 141(1):71-8. PubMed ID: 2454265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.
    Russ G; Poláková K; Kostolanský F; Styk B; Vancíková M
    Acta Virol; 1987 Sep; 31(5):374-86. PubMed ID: 2891276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Production of monoclonal antibodies specific for African swine fever virus following in vitro primary immunization of mouse splenocytes in the presence of stimulated T lymphocyte supernatants.
    Federspiel G; McCullough KC; Kihm U
    J Immunol Methods; 1991 Dec; 145(1-2):71-81. PubMed ID: 1765668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Production of human monoclonal antibody in mouse ascites.
    Truitt KE; Larrick JW; Raubitschek AA; Buck DW; Jacobson SW
    Hybridoma; 1984; 3(2):195-9. PubMed ID: 6480025
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monoclonal antibodies for the control of influenza virusvaccines.
    van de Donk HJ; de Jong JC; van Olderen MF; Osterhaus AD
    Dev Biol Stand; 1984; 57():251-5. PubMed ID: 6526141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Karyological analysis of hybridoma lines producing monoclonal antibodies to viral antigens].
    Rodova MA; Tsoĭ LA; Kushch AA; Novokhatskiĭ AS
    Tsitol Genet; 1985; 19(6):425-8. PubMed ID: 3867189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stability of specific immunoglobulin secretion by EBV-transformed lymphoblastoid cells and human-murine heterohybridomas.
    Glasky MS; Reading CL
    Hybridoma; 1989 Aug; 8(4):377-89. PubMed ID: 2550358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A single-step procedure for cloning and selection of antibody-secreting hybridomas.
    Gherardi E; Pannell R; Milstein C
    J Immunol Methods; 1990 Jan; 126(1):61-8. PubMed ID: 2303725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of two anti-neuraminidase monoclonal antibodies by complement activation.
    Holmes KT; Hampson AW; Raison RL; Webster RG; O'Sullivan WJ; Mountford CE
    Eur J Immunol; 1982 Jun; 12(6):523-6. PubMed ID: 7117362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A single-step technique for selecting and cloning hybridomas for monoclonal antibody production.
    Davis JM
    Methods Enzymol; 1986; 121():307-22. PubMed ID: 3487692
    [No Abstract]   [Full Text] [Related]  

  • 59. Hybridoma antibody production in vitro in type II serum-free medium using Nutridoma-SP supplements. Comparisons with in vivo methods.
    Federspiel G; McCullough KC; Kihm U
    J Immunol Methods; 1991 Dec; 145(1-2):213-21. PubMed ID: 1765654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Production of monoclonal antibodies. The effect of hybridoma concentration on the yield of antibody-producing clones.
    Hadas E; Theilen G
    J Immunol Methods; 1987 Jan; 96(1):3-6. PubMed ID: 3805731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.